Literature DB >> 17033746

Estimation of the duration of vaccine-induced residual protection against severe and fatal smallpox based on secondary vaccination failure.

H Nishiura1, M Eichner.   

Abstract

BACKGROUND: Understanding the loss of vaccine-induced immunity against smallpox is essential in determining the fraction of those who are still protected in the present population and in constructing effective countermeasures against bioterrorist attacks.
METHOD: Three small Australian outbreaks from the 1880s to early 1900s were investigated. Each documented individual age at infection. The case records for Launceston, 1903, further documented the age at vaccination and disease severity, enabling estimates of the duration of protection against severe and fatal smallpox.
RESULTS: A significant association between vaccination and death was observed in the outbreak in Sydney, 1881 (odds ratio of death among vaccinated individuals = 0.3; 95% confidence interval (CI): 0.1, 0.8; p = 0.02), where the time since last vaccination was similar for all vaccinated cases. In Launceston, 1903, where the age at vaccination varied widely, the median duration of partial protection against severe and fatal smallpox was estimated to be 31.7 (95% CI: 13.2, 116.2) and 53.9 (95% CI: 25.6, 123.5) years after vaccination, respectively. Whereas those in their 20s are expected to have the highest frequency of vulnerability to smallpox death in the present population, infections among those in their 30s or 40s are expected to be much less fatal.
CONCLUSION: Long lasting partial protection was suggested from the outbreak records, the estimated durations of which were roughly consistent with those reported previously. In the event of a bioterrorist attack, those involved in emergency tasks before emergency vaccination practices are re-established should ideally be previously vaccinated individuals in their 30s or 40s.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17033746     DOI: 10.1007/s15010-006-6603-5

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  Serological Immunity to Smallpox in New South Wales, Australia.

Authors:  Valentina Costantino; Mallory J Trent; John S Sullivan; Mohana P Kunasekaran; Richard Gray; Raina MacIntyre
Journal:  Viruses       Date:  2020-05-18       Impact factor: 5.048

Review 2.  Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020.

Authors:  Phi-Yen Nguyen; Whenayon Simeon Ajisegiri; Valentina Costantino; Abrar A Chughtai; C Raina MacIntyre
Journal:  Emerg Infect Dis       Date:  2021-04       Impact factor: 6.883

3.  Smallpox and season: reanalysis of historical data.

Authors:  Hiroshi Nishiura; Tomoko Kashiwagi
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-01-04

Review 4.  Extracting key information from historical data to quantify the transmission dynamics of smallpox.

Authors:  Hiroshi Nishiura; Stefan O Brockmann; Martin Eichner
Journal:  Theor Biol Med Model       Date:  2008-08-20       Impact factor: 2.432

5.  Vaccination and clinical severity: is the effectiveness of contact tracing and case isolation hampered by past vaccination?

Authors:  Kenji Mizumoto; Keisuke Ejima; Taro Yamamoto; Hiroshi Nishiura
Journal:  Int J Environ Res Public Health       Date:  2013-02-27       Impact factor: 3.390

6.  EPIPOX: Immunoinformatic Characterization of the Shared T-Cell Epitome between Variola Virus and Related Pathogenic Orthopoxviruses.

Authors:  Magdalena Molero-Abraham; John-Paul Glutting; Darren R Flower; Esther M Lafuente; Pedro A Reche
Journal:  J Immunol Res       Date:  2015-10-28       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.